CDK2 and neoplasm: These results supported our hypothesis that our dimers could target CCNA2 to inhibit SARC by affecting tumor immunity, proliferation, and apoptosis in MG-63 cells.CCNA2 could interact with CDK2 to initiate the cell cycle in vivo (38).